Elizabeth E Reed
Chief Legal Officer and GC · 4 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | May 6, 2026 | Sale | $43.95 | 2,076 | $91.2K | 105,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | May 5, 2026 | Sale | $46.65 | 2,174 | $101.4K | 107,287 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | May 4, 2026 | Sale | $45.00 | 20,000 | $900.0K | 105,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | May 4, 2026 | Option Exercise | $14.81 | 24,250 | $359.2K | 109,461 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 15, 2026 | Sale | $41.83 | 6,785 | $283.8K | 105,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 14, 2026 | Sale | $41.21 | 44,715 | $1.8M | 111,996 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 14, 2026 | Option Exercise | $17.76 | 37,500 | $666.0K | 156,711 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 13, 2026 | Grant/Award | $0.00 | 14,000 | — | 119,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 1, 2026 | Sale | $30.00 | 10,000 | $300.0K | 105,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Apr 1, 2026 | Option Exercise | $15.46 | 10,000 | $154.6K | 115,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Mar 16, 2026 | Sale | $28.09 | 10,000 | $280.9K | 105,211 | |
TVTX | Elizabeth E Reed | Chief Legal Officer and GC | Mar 16, 2026 | Option Exercise | $19.08 | 10,000 | $190.8K | 115,211 |